https://www.selleckchem.com/pr....oducts/emricasan-idn
This report describes the first clinical experience with magnetic resonance imaging-guided focused ultrasound surgery (MRgFUS) using the ExAblate 2100 system for non-invasive breast cancer. Two women with non-invasive breast cancer underwent MRgFUS treatment. One week after the MRgFUS treatment, US-guided vacuum-assisted biopsy was performed for the ablated lesions at the same time as breast-conserving surgery. The patients experienced good cosmetic outcomes and did not experience any severe adverse events, such a
Like
Comment
Share
